Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait
Affiliations
Affiliations
- Service de Bactériologie-Virologie, INSERM U914, Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine et Université Paris-Sud, Le Kremlin-Bicêtre, France.
Abstract
Acinetobacter baumannii is an opportunistic pathogen that is an important source of nosocomial infections. Production of extended-spectrum β-lactamases (ESBLs) of the GES type in A. baumannii has been increasingly reported, and some of these GES-type enzymes possess some carbapenemase activity. Our aim was to analyze the resistance determinants and the clonal relationships of carbapenem-nonsusceptible A. baumannii clinical isolates recovered from hospitals in Kuwait. A total of 63 isolates were analyzed, and all were found to be positive for bla(GES)-type genes. One isolate harbored the bla(GES-14) gene encoding an ESBL with significant carbapenemase activity, whereas the other isolates harbored the bla(GES-11) ESBL gene. Thirty-three isolates coharbored the bla(OXA-23) and bla(GES-11) genes. Analyses of the genetic locations indicated that the bla(GES-11/-14) genes were plasmid located. It is noteworthy that the bla(OXA-23) and bla(GES-11) genes were colocated onto a single plasmid. Nine different pulsotypes were observed among the 63 isolates. This study showed the emergence of GES-type ESBLs in A. baumannii in Kuwait, further suggesting that the Middle East region might be a reservoir for carbapenemase-producing A. baumannii.
Similar articles
Castanheira M, Costello SE, Woosley LN, Deshpande LM, Davies TA, Jones RN.Antimicrob Agents Chemother. 2014 Dec;58(12):7358-66. doi: 10.1128/AAC.03930-14. Epub 2014 Sep 29.PMID: 25267671 Free PMC article.
Lu PL, Doumith M, Livermore DM, Chen TP, Woodford N.J Antimicrob Chemother. 2009 Apr;63(4):641-7. doi: 10.1093/jac/dkn553. Epub 2009 Jan 31.PMID: 19182237
Wang TH, Leu YS, Wang NY, Liu CP, Yan TR.Antimicrob Resist Infect Control. 2018 Oct 11;7:123. doi: 10.1186/s13756-018-0410-5. eCollection 2018.PMID: 30338061 Free PMC article.
Karah N, Giske CG, Sundsfjord A, Samuelsen Ø.Microb Drug Resist. 2011 Dec;17(4):545-9. doi: 10.1089/mdr.2011.0089. Epub 2011 Aug 10.PMID: 21830948
Charfi-Kessis K, Mansour W, Ben Haj Khalifa A, Mastouri M, Nordmann P, Aouni M, Poirel L.Microb Pathog. 2014 Sep;74:20-4. doi: 10.1016/j.micpath.2014.07.003. Epub 2014 Jul 22.PMID: 25057763
Cited by
Sánchez-Urtaza S, Ocampo-Sosa A, Molins-Bengoetxea A, El-Kholy MA, Hernandez M, Abad D, Shawky SM, Alkorta I, Gallego L.Front Cell Infect Microbiol. 2023 Jul 20;13:1208046. doi: 10.3389/fcimb.2023.1208046. eCollection 2023.PMID: 37545857 Free PMC article.
Abouelfetouh A, Mattock J, Turner D, Li E, Evans BA.Microb Genom. 2022 Feb;8(2):000752. doi: 10.1099/mgen.0.000752.PMID: 35104206 Free PMC article.
Alali WQ, AlFouzan W, Dhar R.Germs. 2021 Dec 29;11(4):498-511. doi: 10.18683/germs.2021.1285. eCollection 2021 Dec.PMID: 35096667 Free PMC article.
Nasser M, Palwe S, Bhargava RN, Feuilloley MGJ, Kharat AS.Microorganisms. 2020 Oct 21;8(10):1626. doi: 10.3390/microorganisms8101626.PMID: 33096921 Free PMC article. Review.
Olu-Taiwo MA, Opintan JA, Codjoe FS, Obeng Forson A.Biomed Res Int. 2020 Sep 24;2020:3852419. doi: 10.1155/2020/3852419. eCollection 2020.PMID: 33029505 Free PMC article.